Latest Close
$1.75
News
ACRV
Acrivon Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to ACRV.
1y Change
$0.58 (+49.57%)
Market Cap
$74,903,024.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Acrivon Therapeutics to Present at TD Cowen’s 7th Annual Oncology Innovation Summit
GlobeNewswire • May 21, 2026
Read articleAcrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • May 15, 2026
Read articleAcrivon Therapeutics Q1 Loss Narrows
MT Newswires • May 13, 2026
Read articleAcrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts
GlobeNewswire • May 13, 2026
Read articleAcrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities
GlobeNewswire • Apr 17, 2026
Read articleAcrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
GlobeNewswire • Mar 19, 2026
Read article